Michelle Custead, DVM, MS, DACVIM (Oncology)Board Certified Oncologist

    Dr. Custead received her veterinary degree from VA-MD Regional College of Veterinary Medicine in 2010. After completing her internship in surgery and internal medicine at Garden State Veterinary Specialists in New Jersey, she did a specialty internship in medical oncology in Washington D.C. She then completed her medical oncology residency at Purdue University in 2015.


    Prior to Dr. Custead’s residency at Purdue University, she trained at a specialty oncology private practice with a focus on clinical trial design and management and in a large private practice hospital in New Jersey.

    Why Oncology:

    “I chose this specialty of oncology because cancer can affect all members of our family, even our pets. Getting the news that your pet has cancer is scary but there is hope with many levels of care and new treatments. Knowing that I have helped a family decide what is best for them and their pet while ensuring their pet maintains a good quality of life, brings me great satisfaction.”


    Wisconsin Veterinary Medical Association: 2015 – Present
    American College of Veterinary Internal Medicine: 2012 – Present
    – Finance, Investment, and Audit Committee Member 2019 – Present
    – Oncology Forum Subcommittee Assistant Chair 2019 – 2020, Chair for 2020 – 2021
    Veterinary Cancer Society: 2011, 2014 – Present
    American Veterinary Medical Association: 2010, 2011, 2015 – Present
    American Association of Cancer Research: 2013 – 2014
    Phi Zeta: 2012 – 2013
    Student American Veterinary Medical Association: 2006 – 2011
    Veterinary Business Management Association: 2007 – 2010


    AAVC Residents’ Leadership and Professional Development Conference Award (2015)
    Florence A. Nocka Endowed Award (2009)
    Maryland Higher Education Commission Scholarship (2008)

    Research & Publications:

    Custead M et al. Predictive value of ex vivo biodynamic imaging in determining response to chemotherapy in dogs with spontaneous non-Hodgkin’s lymphomas: a preliminary study. 2015. Converg Sci Phys Oncol 1(1): 1-10.

    Custead M et al. Comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer. Vet Comp Oncol. 2016; May 2. [Epub ahead of print] pmid:27136377.

    Ruff C, Custead MR, et al. Imaging Diagnosis-Nuclear scintigraphic, radiological and pathologic characteristics of metastatic pilomatricoma in a dog. Vet Radiol Ultrasound. 2016. 57(6): 58-62.

    Rancilio NJ, Custead MR, et al. Radiation therapy communication – Reirradiation of a nasal tumor in a brachycephalic dog using intensity modulated radiation therapy-radiation therapy. Veterinary Radiology & Ultrasound. 2016; 57(5): 46-50.

    Start typing and press Enter to search

    Krista Carlson, DVM Emergency ServiceJavier Gallegos, DVM Practice Limited to Surgery